| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009500538 |
| P356 | DOI | 10.1038/323819A0 |
| P698 | PubMed publication ID | 2430188 |
| P2093 | author name string | Goeddel DV | |
| Wong GH | |||
| P2860 | cites work | Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon | Q24294921 |
| Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity | Q24301401 | ||
| Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose | Q24563043 | ||
| An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
| Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies | Q24608447 | ||
| Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose | Q24611198 | ||
| Synthesis of human fibroblast interferon by E. coli | Q24626528 | ||
| Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta | Q24632122 | ||
| Identity of tumour necrosis factor and the macrophage-secreted factor cachectin | Q28286678 | ||
| Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor | Q28507398 | ||
| Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 | ||
| Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae | Q35590901 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor | Q37558444 | ||
| Expression of human immune interferon cDNA in E. coli and monkey cells | Q48405865 | ||
| Human leukocyte interferon produced by E. coli is biologically active | Q48412279 | ||
| Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. | Q53541288 | ||
| Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. | Q54779287 | ||
| Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 | ||
| A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia | Q69803627 | ||
| Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5'-flanking DNA | Q71256949 | ||
| Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity | Q72246984 | ||
| Heterogeneity of poly(I) x poly(C)-induced human fibroblast interferon mRNA species | Q72621125 | ||
| P433 | issue | 6091 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| TNF | Q18032037 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 819-822 | |
| P577 | publication date | 1986-10-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons | |
| P478 | volume | 323 |
| Q42574491 | 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha |
| Q42497551 | 2'-5' oligoadenylate synthetase and its relationship to HLA and genetic markers of insulin-dependent diabetes mellitus |
| Q41436437 | A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor |
| Q40446145 | A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR. |
| Q45756611 | A hemagglutinin-based multipeptide construct elicits enhanced protective immune response in mice against influenza A virus infection. |
| Q38353922 | A hydrophobic region within the adenovirus E1B 19 kDa protein is necessary for the transient inhibition of NF-kappaB activated by different stimuli. |
| Q37412249 | A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia |
| Q30381181 | A novel H1N1 virus causes the first pandemic of the 21st century. |
| Q36802357 | A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes |
| Q43968613 | A sensitive biological assay for interferons |
| Q28748680 | A synthetic adjuvant to enhance and expand immune responses to influenza vaccines |
| Q47307816 | A toxicokinetic study of nickel-induced immunosuppression in rats |
| Q45755984 | Acceleration of virus-induced apoptosis by tumor necrosis factor |
| Q35889174 | Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice |
| Q36689099 | Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis |
| Q45782379 | Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. |
| Q39877642 | Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. |
| Q73605663 | An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats |
| Q33923680 | Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication |
| Q35858429 | Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. |
| Q33937471 | Antigen-specific regulation of T cell-mediated cytokine production |
| Q36380797 | Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors |
| Q67804136 | Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ |
| Q36713993 | Application of Interferons in the Control of Infectious Diseases of Cattle |
| Q38614664 | Astrocytes and intracerebral immune responses |
| Q40403965 | Atypical infectious mononucleosis in a patient receiving tumor necrosis factor alpha inhibitory treatment. |
| Q33641013 | Autocrine secretion of tumor necrosis factor under the influence of interferon-gamma amplifies HLA-DR gene induction in human monocytes |
| Q39188257 | BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha |
| Q40646905 | Beta interferon subtype 1 induction by tumor necrosis factor |
| Q67801964 | Biochemical and immunological responses of hairy cell leukemia patients to interferon beta |
| Q27486090 | Blockade of virus infection by human CD4+ T cells via a cytokine relay network |
| Q41468293 | Both Nsp1β and Nsp11 are responsible for differential TNF-α production induced by porcine reproductive and respiratory syndrome virus strains with different pathogenicity in vitro |
| Q24320374 | Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses |
| Q36368586 | CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability |
| Q77355825 | CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections |
| Q71803263 | CD40 ligand has potent antiviral activity |
| Q39527191 | Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses |
| Q39555654 | Cachetin/TNF: a macrophage protein that induces cachexia and shock |
| Q72719857 | Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B |
| Q36686459 | Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. |
| Q45763622 | Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection |
| Q41065326 | Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. |
| Q44687364 | Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies |
| Q30366836 | Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. |
| Q55287694 | Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections. |
| Q73571738 | Constitutive and induced cytokine production by human placenta and amniotic membrane at term |
| Q33839633 | Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes |
| Q33937276 | Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes |
| Q44354559 | Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha. |
| Q40771947 | Current research on ovine cytokines |
| Q39619946 | Current thoughts on the pathogenesis of graft versus host disease |
| Q37583568 | Cytokine determinants of viral tropism. |
| Q39517091 | Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis |
| Q45426674 | Cytokine levels in Chandipura virus associated encephalopathy in children |
| Q45777869 | Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro |
| Q36954574 | Cytokine regulation of human immunodeficiency virus expression |
| Q26852421 | Cytokine synergy: an underappreciated contributor to innate anti-viral immunity |
| Q36632498 | Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? |
| Q34365540 | Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures |
| Q41672958 | Cytokines and immunity to viral infections |
| Q40896076 | Cytokines, sepsis and immunomodulation |
| Q35224894 | Cytokines: From clone to clinic |
| Q42125469 | Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment. |
| Q30388401 | Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus |
| Q35990527 | Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis |
| Q40741932 | Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? |
| Q41650773 | Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1 |
| Q35224466 | Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus |
| Q41103060 | Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses |
| Q39176802 | Differential TLR7-mediated expression of proinflammatory and antiviral cytokines in response to laboratory and clinical enterovirus strains |
| Q42437635 | Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats |
| Q72660293 | Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity |
| Q43818266 | Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes |
| Q43039106 | Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation |
| Q39577917 | Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. |
| Q36539209 | Diversity of cytokine synthesis and function of mouse CD4+ T cells |
| Q33562993 | Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter |
| Q73115351 | Down-regulation of human tumor necrosis factor-beta gene expression by cells with suppressive activity |
| Q45833840 | Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIVHTLV-IIIB cells |
| Q42987582 | Effect of cytokines on Japanese encephalitis virus production by human monocytes |
| Q70489762 | Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages |
| Q45265417 | Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system |
| Q40151259 | Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor |
| Q67706668 | Effects of PCB (aroclor® 1254) on non-specific immune parameters in rhesus (Macaca mulatta) monkeys |
| Q44433473 | Effects of tumor necrosis factor alpha on replication of varicella-zoster virus |
| Q40771367 | Elevated temperature regulates tumor necrosis factor-mediated immune killing |
| Q36999646 | Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection |
| Q35813788 | Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome |
| Q54329906 | Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma. |
| Q45832900 | Enhancement of human immunodeficiency virus production by natural lymphotoxin |
| Q36434290 | Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication |
| Q34553626 | Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1 |
| Q36424417 | Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes |
| Q37764571 | Evaluation of TNF as antiviral, antibacterial and antiparasitic agent |
| Q41300831 | Evasion of apoptosis by DNA viruses |
| Q42443957 | Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients |
| Q41021483 | Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication |
| Q43466213 | Evidence that deficient IFN-gamma production is a biological basis of herpes simplex virus type-2 neurovirulence |
| Q69049138 | Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis |
| Q36637175 | Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis |
| Q40809743 | Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect |
| Q35263067 | Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo |
| Q38203806 | Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. |
| Q44225233 | Fenfluramine-induced immunosuppression: an in vivo analysis |
| Q36636274 | Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells |
| Q73030905 | Functional effects of lymphotoxin on crushed peripheral nerve |
| Q40372624 | Functional organization of variola major and vaccinia virus genomes |
| Q38659937 | Functionality of Intrinsic Disorder in Tumor Necrosis Factor-α and its Receptors |
| Q35844818 | Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1 |
| Q36259730 | Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells |
| Q38239127 | HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis. |
| Q89881744 | HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs? |
| Q34555372 | HIV-1 infection inhibits cytokine production in human thymic macrophages |
| Q59083904 | HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin |
| Q54348408 | Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors alpha and beta. |
| Q37254436 | Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection |
| Q35613809 | Herpes simplex virus infection and apoptosis |
| Q35873842 | Herpes simplex virus type 2 inhibition of Fas ligand expression |
| Q41617173 | Heterogeneity of cytokine production by human malignant melanoma cells |
| Q68832695 | High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells |
| Q41657342 | Highly efficient expression of proteins encoded by recombinant vaccinia virus in lymphocytes |
| Q45358370 | Highly pathogenic porcine reproductive and respiratory syndrome virus impairs LPS- and poly(I:C)-stimulated tumor necrosis factor-alpha release by inhibiting ERK signaling pathway |
| Q70370045 | Human T cells from autoimmune and normal individuals can produce tumor necrosis factor |
| Q35597937 | Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism |
| Q40100851 | Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus |
| Q36085092 | Human lymphotoxin mutein lacks hypotensive activity but has higher in vivo antitumor activity than lymphotoxin or tumor necrosis factor |
| Q35424419 | Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus |
| Q43046781 | IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. |
| Q33838600 | Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta |
| Q44191604 | Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells |
| Q45852364 | Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. |
| Q37181575 | Immunoregulators in the nervous system |
| Q44913381 | Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon |
| Q67670153 | In Vivo Administration of Cytokine in Allogeneic Bone Marrow Chimeras |
| Q69043503 | In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts |
| Q77194736 | Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol |
| Q41896594 | Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis |
| Q45863869 | Increased tumor necrosis factor-alpha receptor number in chronic hepatitis B virus infection |
| Q70384907 | Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines |
| Q43696516 | Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1. |
| Q39592683 | Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells |
| Q36782589 | Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation |
| Q35853222 | Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis |
| Q40343714 | Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha |
| Q42728753 | Infliximab in ankylosing spondylitis associated with chronic hepatitis B infection. Role of Lamivudine therapy |
| Q41500962 | Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro |
| Q30465682 | Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection |
| Q37899616 | Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor |
| Q27489517 | Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice |
| Q36984332 | Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon |
| Q45788126 | Inhibition of Varicella‐Zoster Virus Glycoprotein Expression by Peripheral Blood Mononuclear Cells |
| Q35105367 | Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis |
| Q33782971 | Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice |
| Q38337427 | Inhibition of tumor necrosis factor-α transcription by Epstein-Barr virus |
| Q52252114 | Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor |
| Q45880144 | Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity |
| Q36353958 | Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression |
| Q40768341 | Interferon cures cells lytically and persistently infected with African swine fever virus in vitro |
| Q36353800 | Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection |
| Q24564284 | Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene |
| Q64378144 | Interferon-γ-induced assembly block in the replication cycle of adenovirus 2: Augmentation by tumour necrosis factor-α |
| Q36357033 | Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells |
| Q36628106 | Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways |
| Q40146112 | Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro |
| Q41472145 | Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. |
| Q34471459 | Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes |
| Q45842746 | Langerhans cells in vaccinia virus infection in mouse skin |
| Q46907034 | Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations |
| Q45879841 | Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes |
| Q37789689 | Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease |
| Q37506760 | Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo |
| Q64917487 | Low ambient humidity impairs barrier function and innate resistance against influenza infection. |
| Q40378948 | Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance |
| Q77402597 | Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia |
| Q44130049 | Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. |
| Q41300846 | M-T2: a poxvirus TNF receptor homologue with dual activities. |
| Q46102734 | MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). |
| Q37384988 | MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases |
| Q28593744 | Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes |
| Q70993875 | Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells |
| Q68194967 | Modulation of tumor necrosis factor release from alveolar macrophages treated with pentamidine isethionate |
| Q41300792 | Molecular basis of immune evasion strategies by adenoviruses |
| Q30834362 | Molecular cloning, expression and characterization of ovine TNFα |
| Q37513594 | Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome |
| Q57201700 | Myasthenia gravis and tumor necrosis factor β polymorphisms: linkage disequilibrium but no association beyond HLA-B8 |
| Q38356806 | Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor |
| Q45740282 | Myxoma virus expresses a TNF receptor homolog with two distinct functions |
| Q40426131 | New and experimental therapies for treating graft-versus-host disease |
| Q41076680 | Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control |
| Q40874333 | Pathogenesis of virus-induced demyelination. |
| Q40754298 | Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancy |
| Q35213606 | Physiological significance of apoptosis during animal virus infection |
| Q72756384 | Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects |
| Q45740651 | Porcine reproductive and respiratory syndrome (PRRS) virus down-modulates TNF-alpha production in infected macrophages |
| Q39668646 | Porcine reproductive and respiratory syndrome virus non-structural protein 1 suppresses tumor necrosis factor-alpha promoter activation by inhibiting NF-κB and Sp1. |
| Q33677323 | Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes |
| Q44003358 | Preactivation of macrophages in mice acutely infected with Schistosoma mansoni |
| Q45374140 | Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients |
| Q36627744 | Production of lipopolysaccharide-induced tumour necrosis factor during influenza virus infection in mice coincides with viral replication and respiratory oxidative burst |
| Q30449838 | Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines |
| Q45854429 | Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease |
| Q35684207 | Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. |
| Q45651755 | Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice |
| Q30845041 | RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages |
| Q38752535 | RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection |
| Q34717937 | Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha |
| Q35077002 | Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57 |
| Q44997882 | Reduction of porcine reproductive and respiratory syndrome virus (PRRSV) infection in swine alveolar macrophages by porcine circovirus 2 (PCV2)-induced interferon-alpha. |
| Q40531456 | Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts. |
| Q45878991 | Regulation of gene expression by cytokines and virus in human cells lacking the type‐I interferon locus |
| Q36828251 | Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses |
| Q27477464 | Relationships between Hepatitis C Virus Replication and CXCL-8 Production In Vitro |
| Q54684335 | Release of tumor necrosis factor-alpha from bovine alveolar macrophages stimulated with bovine respiratory viruses and bacterial endotoxins |
| Q41029868 | Replication of bovine respiratory syncytial virus in bovine and ovine peripheral blood lymphocytes and monocytes and monocytic cell lines |
| Q44548806 | Resistance to ectromelia virus infection in mice. Analysis of H-2-linked gene effects. |
| Q74261251 | Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype |
| Q35766589 | Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity |
| Q41471863 | Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNS. |
| Q45745997 | Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway |
| Q37897635 | Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. |
| Q34552028 | Risk of infections associated with biological treatment in inflammatory bowel disease |
| Q30702806 | Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. |
| Q40569860 | Role of TH1/TH2 cytokines in HIV infection. |
| Q39531883 | Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity |
| Q33813762 | Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection |
| Q45770127 | Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection |
| Q35734045 | Safety of tumour necrosis factor-alpha antagonists |
| Q34557411 | Secretory products of macrophages |
| Q36589648 | Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction |
| Q44998870 | Stimulation of macrophages by endotoxin results in the reactivation of a persistent herpes simplex virus infection |
| Q68502591 | Stimulation of natural killer cytotoxicity by long-term treatment with double-stranded polynucleotides without induction of hyporesponsiveness |
| Q33786998 | Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter |
| Q41349604 | Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene |
| Q41792389 | Structure of tumour necrosis factor |
| Q40977680 | Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? |
| Q58764105 | Subversion of Cytokine Networks by Viruses |
| Q40040075 | Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. |
| Q46614533 | Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system |
| Q27025349 | Systematic review: macrophage activation syndrome in inflammatory bowel disease |
| Q43470154 | T cell therapy of human CMV and EBV infection in immunocompromised hosts |
| Q45789818 | THF gamma 2 stimulates cytokine release by peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection |
| Q35361740 | TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury |
| Q45788355 | Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells |
| Q36816831 | The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α |
| Q24563120 | The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1 |
| Q40064866 | The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells |
| Q28296973 | The IFI-56K and IFI-54K interferon-inducible human genes belong to the same gene family |
| Q36658280 | The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment |
| Q35947867 | The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells |
| Q31465796 | The Rela(p65) subunit of NF-kappaB is essential for inhibiting double-stranded RNA-induced cytotoxicity |
| Q43215263 | The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts |
| Q36620321 | The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. |
| Q35865485 | The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid |
| Q36681830 | The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells |
| Q41392891 | The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor. |
| Q38188500 | The biology of interferon actions |
| Q39204110 | The common mediator of shock, cachexia, and tumor necrosis. |
| Q40506551 | The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications |
| Q52202547 | The effect of exclusive breastfeeding on development and incidence of infection in infants. |
| Q51671315 | The effect of prenatal diazepam exposure on TNF-alpha production by rat splenocytes. |
| Q89505549 | The expression patterns of immune response genes in the Peripheral Blood Mononuclear cells of pregnant women presenting with subclinical or clinical HEV infection are different and trimester-dependent: A whole transcriptome analysis |
| Q36436880 | The molecular action of tumor necrosis factor-alpha |
| Q68498648 | The presence of cachectin/tumor necrosis factor in human disease states |
| Q35586464 | The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2 |
| Q39874089 | The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. |
| Q39572319 | The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response |
| Q44152234 | The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses |
| Q73468006 | The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection |
| Q24629115 | Theiler's virus infection: a model for multiple sclerosis |
| Q36958902 | Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases |
| Q36354711 | Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast |
| Q41103038 | To kill or to cure: options in host defense against viral infection. |
| Q37696067 | Transcriptional control of the TNF gene |
| Q41997239 | Transcriptional modulation of cartilage-specific collagen gene expression by interferon gamma and tumour necrosis factor alpha in cultured human chondrocytes |
| Q83951465 | Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells |
| Q38705509 | Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons |
| Q39510348 | Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition |
| Q39682351 | Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells |
| Q41150293 | Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-kappaB. |
| Q35871524 | Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor |
| Q30857191 | Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data |
| Q36575731 | Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors |
| Q40040068 | Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. |
| Q37513687 | Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation |
| Q37341883 | Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence |
| Q34354649 | Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes |
| Q37205363 | Tumor necrosis factor and interferon: cytokines in harmony |
| Q45009301 | Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro |
| Q69026047 | Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes |
| Q41736198 | Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities |
| Q36357123 | Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis |
| Q36430385 | Tumor necrosis factor regulation of major histocompatibility complex gene expression |
| Q34333796 | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo |
| Q41195314 | Tumor necrosis factor-alpha and interferon-gamma reduce prolactin release in vitro |
| Q44879905 | Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes |
| Q35664715 | Tumor necrosis factor-beta and hypercalcemia |
| Q37965274 | Tumor necrosis factor: an update on basic research and clinical applications |
| Q42737018 | Tumour necrosis factor |
| Q68774951 | Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis |
| Q40644530 | Tumour necrosis factor and associated cytokines in the host's response to malaria |
| Q44635103 | Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve |
| Q36029538 | Tumour necrosis factor in man: clinical and biological observations |
| Q28329734 | Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection |
| Q42087829 | Tumour necrosis factor, cholestatic jaundice, and chronic liver disease |
| Q43906932 | Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants |
| Q37916679 | Tumour necrosis factor: a cytokine with multiple biological activities |
| Q24292403 | Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence |
| Q53369159 | Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma. |
| Q36237901 | Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy |
| Q37598271 | Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver |
| Q45851015 | Virus-vs endotoxin-induced activation of liver macrophages |
| Q35145651 | Viruses and the TNF-related cytokines, an evolving battle |
| Q35831484 | Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes |
| Q71665497 | Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses? |
| Q27486499 | Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes |
Search more.